These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 1384050)
1. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050 [TBL] [Abstract][Full Text] [Related]
2. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527 [TBL] [Abstract][Full Text] [Related]
3. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Burton DR; Barbas CF; Persson MA; Koenig S; Chanock RM; Lerner RA Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10134-7. PubMed ID: 1719545 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875 [TBL] [Abstract][Full Text] [Related]
5. Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop. Duarte CA; Pérez L; Vázquez J; Dueñas M; Vilarrubia OL; Navea L; Valdés R; Reyes O; Montero M; Ayala M; Gavilondo J Immunotechnology; 1996 Feb; 2(1):11-20. PubMed ID: 9373324 [TBL] [Abstract][Full Text] [Related]
6. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Barbas CF; Crowe JE; Cababa D; Jones TM; Zebedee SL; Murphy BR; Chanock RM; Burton DR Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10164-8. PubMed ID: 1279672 [TBL] [Abstract][Full Text] [Related]
7. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Chen SY; Khouri Y; Bagley J; Marasco WA Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092 [TBL] [Abstract][Full Text] [Related]
8. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig. Neshat MN; Goodglick L; Lim K; Braun J Int Immunol; 2000 Mar; 12(3):305-12. PubMed ID: 10700465 [TBL] [Abstract][Full Text] [Related]
10. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775 [TBL] [Abstract][Full Text] [Related]
11. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Burton DR; Pyati J; Koduri R; Sharp SJ; Thornton GB; Parren PW; Sawyer LS; Hendry RM; Dunlop N; Nara PL Science; 1994 Nov; 266(5187):1024-7. PubMed ID: 7973652 [TBL] [Abstract][Full Text] [Related]
12. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Liang M; Chu YK; Schmaljohn C Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211 [TBL] [Abstract][Full Text] [Related]
13. Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1. Srikantan V; Wang B; Satre MA; Ugen KE; Dang K; Scales F; Godillot AP; Williams WV; Weiner DB AIDS; 1994 Nov; 8(11):1525-32. PubMed ID: 7848589 [TBL] [Abstract][Full Text] [Related]
14. Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. Zwick MB; Parren PW; Saphire EO; Church S; Wang M; Scott JK; Dawson PE; Wilson IA; Burton DR J Virol; 2003 May; 77(10):5863-76. PubMed ID: 12719580 [TBL] [Abstract][Full Text] [Related]
15. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event. McInerney TL; McLain L; Armstrong SJ; Dimmock NJ Virology; 1997 Jul; 233(2):313-26. PubMed ID: 9217055 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing human Fab fragments against measles virus recovered by phage display. de Carvalho Nicacio C; Williamson RA; Parren PW; Lundkvist A; Burton DR; Björling E J Virol; 2002 Jan; 76(1):251-8. PubMed ID: 11739690 [TBL] [Abstract][Full Text] [Related]
17. A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus. Cheung SC; Dietzschold B; Koprowski H; Notkins AL; Rando RF J Virol; 1992 Nov; 66(11):6714-20. PubMed ID: 1404611 [TBL] [Abstract][Full Text] [Related]
18. Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries. Moreno de Alborán I; Martínéz-alonso C; Barbas CF; Burton DR; Ditzel HJ Immunotechnology; 1995 May; 1(1):21-8. PubMed ID: 9373330 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258 [TBL] [Abstract][Full Text] [Related]
20. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses. Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]